GRDN

$34.09

Post-MarketAs of Mar 17, 8:00 PM UTC

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$34.09
Potential Downside
46.6%
Whystock Fair Value$18.19
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.16B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
43.71
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
26.61%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.04

Recent News

Simply Wall St.
Mar 15, 2026

Assessing Guardian Pharmacy Services (GRDN) Valuation As Shares Trade Slightly Below Estimated Fair Value

Guardian Pharmacy Services stock context Guardian Pharmacy Services (GRDN) has drawn investor attention after recent trading left the shares at a last close of US$32.59, with returns mixed across the month and the past 3 months. See our latest analysis for Guardian Pharmacy Services. While the latest 1 day share price return of a 2.04% decline and 30 day share price return of a 2.60% decline point to some cooling, the 90 day share price return of 7.06% and 1 year total shareholder return of...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 12, 2026

Guardian Pharmacy Services Inc (GRDN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ...

Guardian Pharmacy Services Inc (GRDN) reports robust financial performance with significant revenue and EBITDA growth, while navigating industry challenges and expanding its operational footprint.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 12, 2026

Guardian Pharmacy Services, Inc. Q4 2025 Earnings Call Summary

Moby summary of Guardian Pharmacy Services, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Motley Fool
Mar 11, 2026

Guardian Pharmacy (GRDN) Earnings Transcript

My name is Ashley Stockton, Vice President, Investor Relations for Guardian Pharmacy Services, Inc. I am joined on today's call by Fred Burke, President and Chief Executive Officer, and David Morris, Chief Financial Officer. After the close today, Guardian Pharmacy Services, Inc. posted its financial results for the quarter ended 12/31/2025.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MarketBeat
Mar 11, 2026

Guardian Pharmacy Services Q4 Earnings Call Highlights

Guardian Pharmacy Services (NYSE:GRDN) reported fourth-quarter and full-year 2025 results that management said exceeded expectations, driven by continued resident growth, higher script volumes, improved vaccine economics, and contributions from acquisitions and greenfield startups. Executives also u

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.